..

Vitalik Buterin quietly pocketed $70K on Polymarket last year by targeting "crazy mode" bets – fading wild predictions like Trump getting a Nobel or the dollar hitting zero. But how does this contrarian approach actually work in volatile prediction markets...

Eli Lilly just unveiled stunning results for their next-gen obesity drug: patients lost up to 28.7% of their body weight in under 70 weeks. This triple agonist is raising the bar in a fiercely competitive market—but is it too powerful for some? The implications for health and stocks are massive...

U.S. flights are stabilizing with cancellations at a weekly low, but as the historic shutdown nears its end, airlines say normalcy won't return overnight. What lingering effects could reshape holiday travel? Dive in to find out...